[The effect of 3,5-dioxo-1,2-diphenyl-4-n-butyl pyrazolidine and 3,5-dioxo-1-phenyl-2-p-hydroxyphenyl-4-butyl pyrazolidine on the incorporation of C14-leucine into the blood plasma proteins of the isolated rat liver].
D001713:Biphenyl Compounds; D001798:Blood Proteins / Q000378:metabolism*; D007930:Leucine / Q000378:metabolism*; D008099:Liver; D008689:Methacrylates; D009943:Organophosphorus Compounds; D010653:Phenylbutazone / Q000031:analogs & derivatives / Q000494:pharmacology*
D001713:Biphenyl Compounds; D001798:Blood Proteins; D007930:Leucine; D008689:Methacrylates; D009943:Organophosphorus Compounds; D010653:Phenylbutazone; C074232:Phenyl-P adhesion promoting monomer; C010574:biphenyl
BLOOD PROTEINS/metabolism; LEUCINE/metabolism; PHENYLBUTAZONE/pharmacology; PHENYLBUTAZONE/related compounds